Healthy adults
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Subjects aged 30 to 59 years old. (2) For impaired glucose tolerance, fasting blood glucose levels are <= 100 mg/dL and HbA1c levels are <=5.8%, for impaired glucose tolerance, fasting blood glucose level are between 110 mg/dL to 125 mg/dL and HbA1c levels are between 5.8%-6.4%. (3) Subjects who can received study explanation and agree to participate in this study with written consent.
Exclusion criteria
Exclusion criteria: (1) Subjects who have serious cardio-vascular, hepatic, renal, respiratory, endocrine, metabolic, or gastrointestinal diseases, or who have a medical history of these diseases. (2) Subjects who take medicine of hyperlipidemia or diabetes. (3) Subjects who have food allergy. (4) Subjects who is now included in other clinical studies, or who will participate in other clinical studies. (5) Subjects who experienced unpleasant feeling during blood collection. (6) Smoker (7) Heavy drinker (Over 30g alcohol per day) (8) Subjects who considered unsuitable for this study by the study investigators.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Glucose metabolism after intervention (blood glucose and insulin levels) | — |
Secondary
| Measure | Time frame |
|---|---|
| Daily variation in blood glucose using CGMs, and GLP-1, GLP, cortisol, keton-body after intervention. | — |
Countries
Japan
Contacts
DRC Co., Ltd Product Testing Department